Mebanazine-d5

CAS: 65-64-5

Ref. 3D-AAA06564

Produktinformation

• Name: Mebanazine-d5
• Synonyme: (1-Phenylethyl)Hydrazine, (α-Methylbenzyl)hydrazine, 1-(1-Phenylethyl)hydrazine, Actamol, Hydrazine, (1-phenylethyl)-, Hydrazine, (α-methylbenzyl)-

Beschreibung

Mebanazine-d5 is a drug that is used to treat Parkinson's disease. It is a dopamine receptor antagonist that blocks the binding of dopamine to its receptor and inhibits the production of IL-2. Mebanazine-d5 has been shown to have genotoxic effects in an in vitro study with human lymphocytes, where it induced chromosomal aberrations and DNA strand breakage. Mebanazine-d5 also showed acute toxicities in mice at oral doses of 600 mg/kg, including lethargy, loss of balance, and ataxia. This drug may inhibit the activity of nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen, by competing for ileum uptake sites on cells lining the small intestine.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 136.19 g/mol
• Formel: C₈H₁₂N₂
• Reinheit: Min. 95%